DNA2 and Miyoshi myopathy: Indeed, DNA2 expression levels were highly correlated with poor prognosis after melphalan- or PI-based therapy, which supports the hypothesis that DNA2 activity inhibition represents a synthetically lethal approach to targeting MM cells with high mitochondrial demand.